PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Cerulean Associates, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cerulean Publishes Strategy to Cut Supplier Risk for Biopharmaceutical and Device Companies - Cerulean has published another section of its Lean Compliance strategy for pharmaceutical, biotechnology and medical device firms, this one focused on minimizing supply chain risk and maximizing return on investment
Cerulean Publishes Strategy to Cut Supplier Risk for Biopharmaceutical and Device Companies

 

NewswireToday - /newswire/ - Williamsburg, VA, United States, 2008/04/14 - Cerulean has published another section of its Lean Compliance strategy for pharmaceutical, biotechnology and medical device firms, this one focused on minimizing supply chain risk and maximizing return on investment.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Compliance directors, CFOs and quality managers now have a proven strategy to control risks associated with their supply chain according to a new article published in the March edition of the peer-reviewed BioProcess International journal, “Shared Risk: A Regulatory Management Strategy.”

Part of Cerulean’s Lean Compliance strategy, the article uses client case studies and the personal experiences of Cerulean’s co-founder, John Avellanet, a former medical device executive, to discuss several core tactics to Cerulean’s Lean Compliance approach when it comes to vendor selection and management:
1. Strategic supplier selection using Cerulean’s Strategy-Impact Matrix
2. Contractual tactics
3. Mistakes to avoid (that often seem like good ideas at first)

“Given the entire Heparin mess, we decided to publish the strategy to give executives a chance to adopt this and quickly achieve a peace of mind,” said Mr. Avellanet. “In fact, I’ve recently been asked to serve on an FDA panel in September to discuss ways to more broadly apply this across the pharmaceutical and biotech industries.”

For non-BioProcess International subscribers, Cerulean will make a free reprint of the article available next month in the Resource Library of the Cerulean website.

Mr. Avellanet is an internationally recognized expert, business adviser and syndicated author on cost-effective regulatory compliance. He publishes the monthly executive newsletter SMARTERCOMPLIANCE™, and is the compliance columnist for the international Journal of Commercial Biotechnology.

Cerulean Associates LLC (ceruleanllc.com) is a small, private compliance consulting company that helps clients achieve cost-effective lean compliance, prevent intellectual property theft and streamline their quality systems.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Cerulean Associates, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Cerulean Publishes Strategy to Cut Supplier Risk for Biopharmaceutical and Device Companies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: John Avellanet - CeruleanLLC.com 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cerulean Associates, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cerulean Associates, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)